본문 바로가기
KERD
논문KCI 등재

Regenerative Medicine Strategies for Treating Neurogenic Bladder

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.

Abstract

Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.

참고문헌 (97)

  1. Ku JH, "The management of neurogenic bladder and quality of life in spinal cord injury", BJU Int, 98, pp.739~745 (2006)
  2. Bauer SB, "Neurogenic bladder: etiology and assessment", Pediatr Nephrol, 23, pp.541~551 (2008)
  3. Chancellor MB, "Pharmacotherapy for neurogenic detrusor overactivity", Am J Phys Med Rehabil, 85, pp.536~545 (2006)
  4. Selzman AA, "Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord", Urol Clin North Am, 20, pp.485~504 (1993)
  5. Reyblat P, "Augmentation cystoplasty: what are the indications", Curr Urol Rep, 9, pp.452~458 (2008)
  6. 정성진, "Spinal Cord", Brain Injury and the Neurogenic Bladder, 201011, pp.37, 537~+[DOI]
  7. Panicker JN, "Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management", Clin Rehabil, 24, pp.579~589 (2010)
  8. Bauer SB, "Predictive value of urodynamic evaluation in newborns with myelodysplasia", JAMA, 252, pp.650~652 (1984)
  9. Wu HY, "Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment", J Urol, 157, pp.2295~2297 (1997)
  10. Scales CD Jr, "Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature", J Urol, 180, pp.2323~2329 (2008)
  11. McDougal WS, "Metabolic complications of urinary intestinal diversion", J Urol, 147, pp.1199~1208 (1992)
  12. Cartwright PC, "Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel", J Urol, 142, pp.1050~1053 (1989)
  13. Cartwright PC, "Bladder autoaugmentation: early clinical experience", J Urol, 142(2 Pt 2), pp.505~508 (1989)
  14. Bellinger MF, "Ureterocystoplasty: a unique method for vesical augmentation in children", J Urol, 149, pp.811~813 (1993)
  15. Churchill BM, "Ureteral bladder augmentation", J Urol, 150(2 Pt 2), pp.716~720 (1993)
  16. Adams MC, "Ureterocystoplasty: is it necessary to detubularize the distal ureter", J Urol, 160(3 Pt 1), pp.851~853 (1998)
  17. Hasetine W, "A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower", Health Forum J, 42, pp.28~65 (1999)
  18. Chun SY, "Identification and characterization of bioactive factors in bladder submucosa matrix", Biomaterials, 28, pp.4251~4256 (2007)
  19. Sharon JL, "The use of N-terminal immobilization of PTH(1-34) on PLGA to enhance bioactivity", Biomaterials, 29, pp.3137~3142 (2008)
  20. Kim BS, "Biomaterials for tissue engineering", World J Urol, 15, pp.2~9 (2000)
  21. Tabata Y, "Current status of regenerative medical therapy based on drug delivery technology", Reprod Biomed Online, 16, pp.70~80 (2008)
  22. Atala A, "Endoscopic treatment of vesicoureteral reflux with a self-detachable balloon system", J Urol, 148(2 Pt 2), pp.724~727 (1992)
  23. Riehmann M, "The Hydroflex penile prosthesis: a test case for the introduction of new urological technology", J Urol, 149(5 Pt 2), pp.1304~1307 (1993)
  24. Levesque PE, "Ten-year experience with the artificial urinary sphincter in children", J Urol, 156(2 Pt 2), pp.625~628 (1996)
  25. Ikada Y, "Challenges in tissue engineering", J R Soc Interface, 3, pp.589~601 (2006)
  26. Atala A, "Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro", J Urol, 148(2 Pt 2), pp.658~662 (1992)
  27. Atala A, "Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux", J Urol, 150(2 Pt 2), pp.745~747 (1993)
  28. Atala A, "Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle", J Urol, 150(2 Pt 2), pp.608~612 (1993)
  29. Atala A, "Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension", J Urol, 152(2 Pt 2), pp.641~643 (1994)
  30. Atala A, "Tissue engineering, stem cells, and cloning for the regeneration of urologic organs", Clin Plast Surg, 30, pp.649~667 (2003)
  31. Atala A, "Recent applications of regenerative medicine to urologic structures and related tissues", Curr Opin Urol, 16, pp.305~309 (2006)
  32. Atala A, "A novel inert collagen matrix for hypospadias repair", J Urol, 162(3 Pt 2), pp.1148~1151 (1999)
  33. Atala A, "Autologous cell transplantation for urologic reconstruction", J Urol, 159, pp.2~3 (1998)
  34. Cilento BG, "Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro", J Urol, 152(2 Pt 2), pp.665~670 (1994)
  35. Yoo JJ, "A novel gene delivery system using urothelial tissue engineered neo-organs", J Urol, 158(3 Pt 2), pp.1066~1070 (1997)
  36. Fauza DO, "Videofetoscopically assisted fetal tissue engineering: skin replacement", J Pediatr Surg, 33, pp.357~361 (1998)
  37. Fauza DO, "Videofetoscopically assisted fetal tissue engineering: bladder augmentation", J Pediatr Surg, 33, pp.7~12 (1998)
  38. Yoo JJ, "Bladder augmentation using allogenic bladder submucosa seeded with cells", Urology, 51, pp.221~225 (1998)
  39. Amiel GE, "Current and future modalities for functional renal replacement", Urol Clin North Am, 26, pp.235~246 (1999)
  40. Kershen RT, "New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux", Urol Clin North Am, 26, pp.81~94 (1999)
  41. Oberpenning F, "De novo reconstitution of a functional mammalian urinary bladder by tissue engineering", Nat Biotechnol, 17, pp.149~155 (1999)
  42. Park HJ, "Reconstitution of human corporal smooth muscle and endothelial cells in vivo", J Urol, 162(3 Pt 2), pp.1106~1109 (1999)
  43. Scriven SD, "Reconstitution of human urothelium from monolayer cultures", J Urol, 158(3 Pt 2), pp.1147~1152 (1997)
  44. Liebert M, "Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction", Differentiation, 61, pp.177~185 (1997)
  45. Puthenveettil JA, "Replicative senescence in human uroepithelial cells", Adv Exp Med Biol, 462, pp.83~91 (1999)
  46. Liebert M, "Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype", Semin Urol, 9, pp.124~130 (1991)
  47. Harriss DR, "Smooth muscle cell culture: a new approach to the study of human detrusor physiology and pathophysiology", Br J Urol, 75(Suppl 1), pp.18~26 (1995)
  48. Freeman MR, "Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder", J Clin Invest, 99, pp.1028~1036 (1997)
  49. Solomon LZ, "Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties", J Lab Clin Med, 132, pp.279~283 (1998)
  50. Lobban ED, "Uroplakin gene expression by normal and neoplastic human urothelium", Am J Pathol, 153, pp.1957~1967 (1998)
  51. Nguyen HT, "Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells", In Vitro Cell Dev Biol Anim, 35, pp.371~375 (1999)
  52. Rackley RR, "Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction", J Urol, 162, pp.1812~1816 (1999)
  53. Lin HK, "Characterization of neuropathic bladder smooth muscle cells in culture", J Urol, 171, pp.1348~1352 (2004)
  54. 윤철용, "Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders", JOURNAL OF UROLOGY, 168(4), pp.1853~1857, LIPPINCOTT WILLIAMS WILKINS
  55. Brivanlou AH, "Stem cells, Setting standards for human embryonic stem cells", Science, 300, pp.913~916 (2003)
  56. Devine SM, "Mesenchymal stem cells: will they have a role in the clinic", J Cell Biochem Suppl, 38, pp.73~79 (2002)
  57. Jiang Y, "Pluripotency of mesenchymal stem cells derived from adult marrow", Nature, 418, pp.41~49 (2002)
  58. Caplan AI, "Adult mesenchymal stem cells for tissue engineering versus regenerative medicine", J Cell Physiol, 213, pp.341~347 (2007)
  59. da Silva Meirelles L, "In search of the in vivo identity of mesenchymal stem cells", Stem Cells, 26, pp.2287~2299 (2008)
  60. De Coppi P, "Isolation of amniotic stem cell lines with potential for therapy", Nat Biotechnol, 25, pp.100~106 (2007)
  61. Hochedlinger K, "Nuclear transplantation, embryonic stem cells and the potential for cell therapy", Hematol J, 5(Suppl 3), pp.S114~S117 (2004)
  62. Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
  63. Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
  64. Yu J, "Induced pluripotent stem cell lines derived from human somatic cells", Science, 318, pp.1917~1920 (2007)
  65. Apodaca G, "The uroepithelium: not just a passive barrier", Traffic, 5, pp.117~128 (2004)
  66. Negrete HO, "Permeability properties of the intact mammalian bladder epithelium", Am J Physiol, 271, pp.F886~F894 (1996)
  67. Kaefer M, "Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments", J Urol, 160(6 Pt 1), pp.2187~2190 (1998)
  68. Kaefer M, "Continent urinary diversion: the Children’s Hospital experience", J Urol, 157, pp.1394~1399 (1997)
  69. Atala A, "Commentary on the replacement of urologic associated mucosa", J Urol, 156, pp.338~339 (1995)
  70. Probst M, "Reproduction of functional smooth muscle tissue and partial bladder replacement", Br J Urol, 79, pp.505~515 (1997)
  71. Sutherland RS, "Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix", J Urol, 156(2 Pt 2), pp.571~577 (1996)
  72. Piechota HJ, "In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft", J Urol, 159, pp.1717~1724 (1998)
  73. Wefer J, "Time dependent smooth muscle regeneration and maturation in a bladder acellular matrix graft: histological studies and in vivo functional evaluation", J Urol, 165, pp.1755~1759 (2001)
  74. Kikuno N, "Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder", BJU Int, 103, pp.1424~1428 (2009)
  75. Badylak SF, "Small intestinal submucosa as a large diameter vascular graft in the dog", J Surg Res, 47, pp.74~80 (1989)
  76. Badylak SF, "The extracellular matrix as a scaffold for tissue reconstruction", Semin Cell Dev Biol, 13, pp.377~383 (2002)
  77. Kropp BP, "Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations", J Urol, 155, pp.2098~2104 (1996)
  78. Kropp BP, "Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility", J Urol, 156(2 Pt 2), pp.599~607 (1996)
  79. Vaught JD, "Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: functional innervation and receptor expression", J Urol, 155, pp.374~378 (1996)
  80. Portis AJ, "Laparoscopic augmentation cystoplasty with different biodegradable grafts in an animal model", J Urol, 164, pp.1405~1411 (2000)
  81. Landman J, "Laparoscopic mid sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year followup", J Urol, 171(6 Pt 1), pp.2450~2455 (2004)
  82. Kropp BP, "Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa", J Urol, 172(4 Pt 2), pp.1710~1713 (2004)
  83. Jayo MJ, "Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies", J Urol, 180, pp.392~397 (2008)
  84. Zhang Y, "Bladder reconstruction by tissue engineering--with or without cells", J Urol, 180, pp.10~11 (2008)
  85. Nguyen MM, "Urothelial progenitor cells: regional differences in the rat bladder", Cell Prolif, 40, pp.157~165 (2007)
  86. Kurzrock EA, "Label-retaining cells of the bladder: candidate urothelial stem cells", Am J Physiol Renal Physiol, 294, pp.F1415~F1421 (2008)
  87. Shukla D, "Bone marrow stem cells for urologic tissue engineering", World J Urol, 26, pp.341~349 (2008)
  88. Anumanthan G, "Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium", J Urol, 180(4 Suppl), pp.1778~1783 (2008)
  89. Oottamasathien S, "Directed differentiation of embryonic stem cells into bladder tissue", Dev Biol, 304, pp.556~566 (2007)
  90. 제임스유, "Urine Derived Cells are a Potential Source for Urological Tissue Reconstruction", JOURNAL OF UROLOGY, 180(5), pp.2226~2233, ELSEVIER SCIENCE INC
  91. Wu S, "Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering", Biomaterials, 32, pp.1317~1326 (2011)
  92. de Boer WI, "Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo", Am J Pathol, 145, pp.1199~1207 (1994)
  93. Jayo MJ, "Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct", Regen Med, 3, pp.671~682 (2008)
  94. Kwon TG, "Local and systemic effects of a tissue engineered neobladder in a canine cystoplasty model", J Urol, 179, pp.2035~2041 (2008)
  95. Zhang Y, "Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model", BJU Int, 98, pp.1100~1105 (2006)
  96. Farhat WA, "Does mechanical stimulation have any role in urinary bladder tissue engineering", World J Urol, 26, pp.301~305 (2008)
  97. Atala A, "Tissue-engineered autologous bladders for patients needing cystoplasty", LANCET, 367(9518), pp.1241~1246, LANCET LTD

관련 논문AI추천

Stem Cell Therapy for Neurogenic Bladder After Spinal Cord Injury: Clinically Possible?김계환, 김수진, 나영길, 박종목, 조영삼대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제2호Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic ReviewFariba Pashazadeh, Hanieh Salehi-Pourmehr, Javad Mahmoudi, Narjes Maasoumi, Reza Rahbarghazi, Saeed Sadigh-Eteghad, Sakineh Hajebrahimi대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제3호The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder오승준, 정성진대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제3호Histological Examination of Engineered Mesenchymal Stem Cells Improve Bladder Function in Rat조은경, Seung Hwan Jeon대한임상검사과학회 · 대한임상검사과학회지2020 · 제52권 제2호Management of Urinary Incontinence With Underactive Bladder: A Review김준철, 조강준대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제2호Long-term Outcomes of Augmentation Cystoplasty in a Pediatric Population With Refractory Bladder Dysfunction: A 12-Year Follow-up Experience at Single CenterAhmed Almathami, Ahmed Alshammari, Ahmed Althobity, Hamdan Alhazmi, Mohammed Al-Shayie, Santiago Vallasciani, Shahbaz Mehmood, Waleed Mohamed Altaweel대한배뇨장애요실금학회 · International Neurourology Journal2018 · 제22권 제4호

이 간행물의 다른 논문 (12건)